4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-038862
Options or other derivatives
- Director acquired 26,025 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| WITTE OWEN N. Director | 2019-06-06 | Grant or award · Stock Option (Right to Buy) | +26,025 | 26,025 | D | ||
Loading xslF345X03/doc4.xml…